ER-Initiated Palliative Care Consult Ups QoL in Advanced CA

This article originally appeared here.
Share this content:
ER-Initiated Palliative Care Consult Ups QoL in Advanced CA
ER-Initiated Palliative Care Consult Ups QoL in Advanced CA

FRIDAY, Jan. 15, 2016 (HealthDay News) -- For patients with advanced cancer, emergency department-initiated palliative care consultation is associated with improved quality of life, according to a study published online Jan. 14 in JAMA Oncology.

Corita R. Grudzen, M.D., from the New York University School of Medicine in New York City, and colleagues compared quality of life, depression, health care utilization, and survival in patients with advanced cancer. A total of 136 patients who presented to the emergency department were enrolled and randomized to emergency department-initiated palliative care (69 patients) or usual care (67 patients).

The researchers found that patients randomized to palliative care had significantly higher quality of life, as measured by a change in Functional Assessment of Cancer Therapy-General Measure score from enrollment to 12 weeks (mean increase of 5.91 points, versus 1.08 in controls; P = 0.03). Compared with the control group, median estimates of survival were longer in the intervention group, although the difference was not statistically significant (289 versus 132 days; P = 0.20). No significant differences were seen in depression, intensive care unit admission, and discharge to hospice.

"Emergency department-initiated palliative care consultation in advanced cancer improves quality of life in patients with advanced cancer and does not seem to shorten survival; the impact on health care utilization and depression is less clear and warrants further study," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »